Tag: FreeStyle Libre
Studies link Abbott CGM with reduced hospitalizations
May 19, 2025HME News Staff
ABBOTT PARK, Ill. – Abbott’s FreeStyle Libre continuous glucose monitoring technology is associated with a significant reduction in the risk of hospitalization for heart complications in people with diabetes, according to the results of the company’s REFLECT real-world studies.
For the first time, Abbott says, data show that CGM technology can help lessen the severity of cardiovascular complications – regardless of a prior history of low blood sugar events or heart...
The surge: Riding the wave of diabetes tech
May 2, 2025Theresa Flaherty, Managing Editor
I was talking to Dr. Arti Masturzo, the chief medical officer at CCS, about the company’s latest study, which connects the importance of preserving CGM access through DME channels with addressing physician burnout.
That’s right: There’s so many people being diagnosed with diabetes, many of whom clamoring for a continuous glucose monitor - what she referred to as “the surge” - that physicians report being overwhelmed not only by the sheer volume of patients,...
Abbott integrates Libre data with Epic EHR system
April 29, 2025HME News Staff
ABBOTT PARK, Ill. – Abbott has entered a first-of-its-kind agreement to integrate data from FreeStyle Libre CGM systems directly into Epic electronic health record systems in the United States, allowing clinicians to view data from within the systems before, during and after meeting with patients.
The collaboration aims to improve workflow efficiency through Epic’s Aura software, which brings health systems together with diagnostic labs and medical device manufacturers.
"Our...
In brief: Numotion reports data incident, Abbott launches app
April 23, 2025HME News Staff
PHOENIX - Numotion recently learned that certain employee email accounts were accessed without authorization on several occasions between Sept. 2, 2024, and Nov. 18, 2024, the company said in a Notice of Data Security Incident posted on its website.
In the notice, the company states: “Numotion has no reason to believe that anyone was trying to access personal information in the accounts, and there is no indication that any information has been used for fraud or identity theft....
In brief: Carelon buys CareBridge, 20 reps sign letter, OIG adds reviews
November 1, 2024HME News Staff
INDIANAPOLIS – Carelon, a division of Elevance Health, recently entered into an agreement to acquire CareBridge, a value-based manager of home and community-based services for chronic and complex members that will serve as the foundation for its home health business, company officials announced during a conference call to discuss its third quarter 2024 financial results.
"We're excited to continue to serve all its customers and members,” said Gail Koziara Boudreaux,...
Beta Bionics integrates with Libre 3 Plus
October 31, 2024HME News Staff
IRVINE, Calif. – Beta Bionics has launched the integration of its flagship iLet Bionic Pancreas with Abbott’s FreeStyle Libre 3 Plus sensor. The iLet Bionic Pancreas is an autonomous insulin delivery system that streamlines diabetes management and is the first insulin delivery system in the United States to connect to Abbott’s FreeStyle Libre 3 Plus sensor, whose readings every minute will help iLet calculate insulin doses. “Beta Bionics continues to move at lightning speed...
FDA says OK to leave FreeStyle Libre CGMs on for imaging
October 30, 2024HME News Staff
ABBOTT PARK, Ill. – Users of the FreeStyle Libre 2 and 3 continuous glucose monitoring systems from Abbott no longer need to remove and discard the devices for imaging procedures, such as X-rays, CT scans and MRIs. The U.S. Food and Drug Administration has cleared the removal of the imaging contraindication, making Abbott’s systems the first and only patient-applied CGM sensors approved for these screenings. "For people with diabetes, especially those using insulin, removing a CGM...
Abbott recalls certain sensors
September 9, 2024HME News Staff
ABBOTT PARK, Ill. - Abbott has issued a recall for certain FreeStyle Libre 3 sensors due to a risk for inaccurate high glucose readings. On July 24, the company sent all affected customers an urgent medical device recall recommending they, among other things, immediately discontinue use and dispose of any affected sensors, and request a replacement for any affected seniors. Abbott initiated the recall after finding that a small number of FreeStyle Libre 3 sensors may provide incorrect high glucose...
In brief: MA payments, tech stage, device risk, Cardinal acquisition
February 2, 2024HME News Staff
WASHINGTON – CMS has released a Calendar Year 2025 Advance Notice for the Medicare Advantage and Medicare Part D Prescription Drug Programs that would pave the way for payments to MA plans to increase on average by 3.7%, or more than $16 billion, from 2024 to 2025.
“CMS continues to ensure that Medicare Advantage and Part D prescription drug plans remain strong, stable and affordable offerings,” said CMS Administrator Chiquita Brooks-LaSure. “The Advance Notice upholds...
ADS adds Libre 2 Plus sensor
January 31, 2024HME News Staff
CARLSBAD, Calif. — Advanced Diabetes Supply (ADS), a national distributor of diabetes devices under the ADS and US MED brands, is now carrying the new FreeStyle Libre 2 Plus sensor, the first DME provider in the country to offer consumers the 15-day sensor. “The FreeStyle Libre 2 Plus is an exciting advancement in diabetes health technology and is the only 15-day non-implantable continuous glucose monitoring (CGM) sensor in the U.S.,” said Bill Mixon, CEO of ADS. “As leading...